NOVA63035
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NOVA63035, covering 2015-05-27 to 2015-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy [Phase 1]